Case report: AA-amyloidosis caused by visceral leishmaniasis in a human immunodeficiency virus-infected patient

American Journal of Tropical Medicine and Hygiene

Volumn 81, Issue 2, 2009, Pages 209-212

  De Vallière, Serge ^b   Mary, Charles ^c   Joneberg, Jeanna E ^b   Rotman, Samuel ^b   Bullani, Roberto ^b   Greub, Gilbert ^b   Gillmore, Julian D ^d   Buffet, Pierre A ^e   Tarr, Philip E ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c TIMONE HOSPITAL   (France)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; AMYLOID A PROTEIN; ANTIMONY; CD4 ANTIGEN; DNA; LAMIVUDINE; LEISHMANIA ANTIGEN; MEGLUMINE ANTIMONATE; MILTEFOSINE; PARASITE ANTIGEN; RITONAVIR; UNCLASSIFIED DRUG; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIPROTOZOAL AGENT; MEGLUMINE; MEGLUMINE ANTIMONIATE; ORGANOMETALLIC COMPOUND;

AA AMYLOIDOSIS; ADULT; AMYLOIDOSIS; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CASE REPORT; CD4+ T LYMPHOCYTE; CRYOGLOBULINEMIA; DRUG WITHDRAWAL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; KIDNEY FAILURE; LEISHMANIA INFANTUM; LYMPHOCYTOPENIA; MALE; NUCLEOTIDE SEQUENCE; PANCYTOPENIA; RELAPSE; TREATMENT RESPONSE; VISCERAL LEISHMANIASIS;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; LEISHMANIA INFANTUM;

AMPHOTERICIN B; AMYLOIDOSIS; ANTI-HIV AGENTS; ANTIPROTOZOAL AGENTS; HIV INFECTIONS; HUMANS; LEISHMANIASIS, VISCERAL; MALE; MEGLUMINE; ORGANOMETALLIC COMPOUNDS; YOUNG ADULT;

EID: 68549115292     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2009.81.209     Document Type: Article

References (16)

1. Oliveira AV, Roque-Barreira MC, Sartori A, Campos-Neto A, Rossi MA, 1985. Mesangial proliferative glomerulonephritis associated with progressive amyloid deposition in hamsters experimentally infected with Leishmania donovani. Am J Pathol 120: 256-262. (Pubitemid 16255958)
2. Poli A, Abramo F, Mancianti F, Nigro M, Pieri S, Bionda A, 1991. Renal involvement in canine leishmaniasis. A light-microscopic, immunohistochemical and electron-microscopic study. Nephron 57: 444-452.
3. Croan DG, Morrison DA, Ellis JT, 1997. Evolution of the genus Leishmania revealed by comparison of DNA and RNA polymerase gene sequences. Mol Biochem Parasitol 89: 149-159.
4. Mary C, Faraut F, Drogoul MP, Xeridat B, Schleinitz N, Cuisenier B, Dumon H, 2006. Reference values for Leishmania infantum parasitemia in different clinical presentations: quantitative polymerase chain reaction for therapeutic monitoring and patient follow-up. Am J Trop Med Hyg 75: 858-863. (Pubitemid 351627530)
5. Navarro M, Bonet J, Bonal J, Romero R, 2006. Secondary amyloidosis with irreversible acute renal failure caused by visceral leishmaniasis in a patient with AIDS. Nefrologia 26: 745-746.
6. Alex S, Criado C, Fernandez-Guerrero ML, de Gorgolas M, Petkov V, Garcia Perez A, Egido J, Barat A, Manzarbeitia F, Caramelo C, Ortiz A, 2008. Nephrotic syndrome complicating chronic visceral leishmaniasis: re-emergence in patients with AIDS. Clin Nephrol 70: 65-68. (Pubitemid 352005974)
7. Lachmann HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD, Hawkins PN, 2007. Natural history and outcome in systemic AA amyloidosis. N Engl J Med 356: 2361-2371. (Pubitemid 46883770)
8. Osick LA, Lee TP, Pedemonte MB, Jacob L, Chauhan P, Navarro C, Comer GM, 1993. Hepatic amyloidosis in intravenous drug abusers and AIDS patients. J Hepatol 19: 79-84. (Pubitemid 23338014)
9. Cozzi PJ, Abu-Jawdeh GM, Green RM, Green D, 1992. Amyloidosis in association with human immunodeficiency virus infection. Clin Infect Dis 14: 189-191.
10. Mery JP, Delahousse M, Nochy D, 1993. Amyloidosis and infection due to human immunodeficiency virus. Clin Infect Dis 16: 733-734. (Pubitemid 23136583)
11. Chan-Tack KM, Ahuja N, Weinman EJ, Wali RK, Uche A, Greisman LA, Drachenberg C, Hawkins PN, Redfield RR, 2006. Acute renal failure and nephrotic range proteinuria due to amyloidosis in an HIV-infected patient. Am J Med Sci 332: 364-367. (Pubitemid 46005834)
12. Mira JA, Corzo JE, Rivero A, Macias J, De Leon FL, Torre-Cisneros J, Gomez-Mateos J, Jurado R, Pineda JA, 2004. Frequency of visceral leishmaniasis relapses in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy. Am J Trop Med Hyg 70: 298-301. (Pubitemid 38366535)
13. Riera C, Fisa R, Ribera E, Carrio J, Falco V, Gallego M, Moner L, Molina I, Portus M, 2005. Value of culture and nested polymerase chain reaction of blood in the prediction of relapses in patients co-infected with leishmania and human immunodeficiency virus. Am J Trop Med Hyg 73: 1012-1015. (Pubitemid 43038245)
14. Bourgeois N, Lachaud L, Reynes J, Rouanet I, Mahamat A, Bastien P, 2008. Long-term monitoring of visceral leishmaniasis in patients with AIDS: relapse risk factors, value of polymerase chain reaction, and potential impact on secondary prophylaxis. J Acquir Immune Defic Syndr 48: 13-19. (Pubitemid 351600853)
15. Buffet P, Deray G, Grogl M, Martinez F, Jacobs C, 1995. Tolerance and pharmacokinetics of antimony in a patient with renal failure. Nephrol Dial Transplant 10: 1477.
16. Sindermann H, Engel KR, Fischer C, Bommer W, 2004. Oral miltefosine for leishmaniasis in immunocompromised patients: compassionate use in 39 patients with HIV infection. Clin Infect Dis 39: 1520-1523. (Pubitemid 39518218)